Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India

BMJ

Volumn 316, Issue 7139, 1998, Pages 1200-1207

  Jha, T K ^a   Olliaro, P ^b   Thakur, C P N ^a   Kanyok, T P ^b   Singhania, B L ^a   Singh, I J ^a   Singh, N K P ^a   Akhoury, S ^a   Jha, S ^a   Lockwood, Diana N J ^c  

^a Kala azar Research Centre   (India)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PAROMOMYCIN; SERUM ALBUMIN; STIBOGLUCONATE SODIUM;

ALBUMIN BLOOD LEVEL; AMASTIGOTE; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEVER; GIEMSA STAIN; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY FUNCTION TEST; LEUKOCYTE COUNT; LIVER FUNCTION TEST; LIVER SIZE; MAJOR CLINICAL STUDY; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPLEEN SIZE; THROMBOCYTE COUNT; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIMONY SODIUM GLUCONATE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAMUSCULAR; LEISHMANIASIS, VISCERAL; MIDDLE AGED; PAROMOMYCIN; RISK ASSESSMENT; SCHISTOSOMICIDES; TREATMENT OUTCOME;

EID: 0032542932     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7139.1200     Document Type: Article

References (26)

1. Singh NKP, Jha TK, Singh IJ, Jha S. Combination therapy in Kala-Azar. J Assoc Physicians India 1995; 43: 319-332.
2. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46: 296-306.
3. Olliaro PL, Bryceson ADM. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today 1993; 9: 323-328.
4. De Lalla F, Pellizzer G, Gradoni L, Vespignani M, Franzetti M, Stecca C. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis. Clin Infect Dis 1993; 16: 730-731.
5. Donovan KL, White AD, Cooke DA, Fisher DJ. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient. J Infect 1990; 21: 107-110.
6. Braconien JH, Miorner H. Recurrent episodes of thrombocytopenia during treatment with sodium stibogluconate. J Antimicrob Chemother 1993; 31: 187-188.
7. Balzan M, Fenech F. Acute renal failure in visceral leishmaniasis treated with sodium stibogluconate. Trans R Soc Trop Med Hyg 1992; 86: 515-516.
8. Singh NKP, Sharma D, Jha TK. Kala-azar mortality in hospitalized cases in North Bihar, India. J Assoc Physicians India 1989; 37: 514-516.
9. Schilling RT, Schaffner CP. Differentiation of catenulin-neomycin antibiotics: identity of catenulin, paromomycin, hydroxymycin and aminosidin. Antimicrob Agents Chemother 1961; 4: 274-285.
10. Kellina OL. A study on experimental leishmaniasis in white rats. Med Parasitologii 1961; 30: 684-691.
11. Neal RA. The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis. Ann Trop Med Parasitol 1968; 62: 54-62.
12. Neal RA, McCoy N, Allen S, Olliaro P, Croft SL. The sensitivity of Leishmania species to aminosidine J Antimicrob Chemother 1995; 35: 577-84.
13. Chunge CN, Owate J, Pamba HO, Donno L. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans R Soc Trop Med Hyg 1990; 84: 221-225.
14. Seaman J, Pryce D, Sondorp HE, Moody A, Bryceson AD, Davidson RN. Epidemic visceral leishmaniasis in Sudan: A randomised trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J Infect Dis 1993; 168: 715-720.
15. Thakur CP, Olliaro P, Gothoskar S, Bhowmick S, Choudhury BK, Prasad S, et al. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (=paromomycin)-antimonial compounds, a pilot study in Bihar, India. Trans R Soc Trop Med Hyg 1992; 86: 617-619.
16. Thakur CP, Bhowmick S, Dolfi L, Olliaro P. Aminosidine plus sodium stibogluconate for the treatment of Indian Kala-azar: A randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg 1995; 88: 219-223.
17. Scott JAG, Davidson RN, Moody AH, Grant HR, Felmingham D, Scott GMS, et al. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg 1992; 86: 617-619.
18. Expert Committee on the Control of the Leishmaniases. Control of the leishmaniases: report of a WHO expert committee. Geneva: Schüler SA, 1990. (WHO Technical Series No 793.)
19. Franke ED, Wignall S, Cruz ME, Rosales E, Tovar AA, Lucas CM, et al. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med 1990; 113: 934-940.
20. Jha TK, Olliaro P, Thakur CPN, Kanyok TP, Singhania BL, Singh IJ, et al. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ 1998; 316: 1200-1205.
21. Mishra M, Biswas UK, Jha AM, Khan AB. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet 1994; 344: 1599-1600.
22. Jha TK, Giri YN, Singh TK, Jha S. Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India. Am J Trop Med Hyg 1995; 52: 536-538.
23. Sundar S, Agrawal NK, Sinha PR, Horwith GS, Murray HW. Short-course, low dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann Intern Med 1997; 127: 133-137.
24. Scott JA, Davidson RN, Moody AH, Grant HR, Felmingham D, Scott GM, et al. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg 1992; 86: 617-619.
25. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997; 10: 298-319.
26. Thakur CP, Bhowmick S, Dolfi L, Olliaro P. Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: A randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg 1995; 89: 219-223.